1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
P&S Robotics Co., Ltd.

P&S Robotics Co., Ltd.

KKRX:460940
3,945.00
KRW
-55.00
(-1.37%)
70.21EPS
70.15P/E
66.60BMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1,262.51
1,026.92
591.32
1,253.95
587.61
371.93
Basic EPS, GAAP
375
296
138.79
409.87
211.52
70.56
Free Cash Flow per Basic Share
616.2
191.6
63.73
211.31
-260.12
-239.57
Dividend per Share
- -
- -
- -
- -
24.89
- -
Book Value per Share
887.15
1,191.68
1,516.07
6,173.95
3,291.88
3,164.89
Tangible Book Value per Share
881.31
1,184
1,506.82
6,168.16
3,288.23
3,160.88
Basic Weighted Avg Shares
5
5
10
6
13
16
Sales/Revenue/Turnover
5,815
5,215
6,009
7,105
7,639
6,094
Operating Margin (%)
36.08
38.64
21.96
22.75
13.12
-6.88
Depreciation Expense
245
102
118
137
233
260
Net Income, GAAP
1,727
1,503
1,410
2,322
2,750
1,156
Effective Tax Rate (%)
15.34
10.54
4.71
8.86
- -
- -
Profit Margin (%)
29.7
28.82
23.47
32.69
36
18.97
Working Capital
3,169
4,177
5,722
37,760
38,267
34,464
LT Debt
1,196
225
178
311
849
1,013
Total Equity
4,508
6,055
7,704
39,956
43,227
42,585
Return on Invested Capital (%)
- -
24.16
15.66
6
- -
- -
Return on Capital (%)
- -
21.23
18.19
9.6
- -
- -
Return on Common Equity (%)
- -
28.46
20.5
9.75
6.61
2.79

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Mar'26
Jun'26
ST Debt
113
123
142
LT Borrowings
- -
- -
- -
LT Finance Leases
782
819
1,013
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
95,203
100,780
66,604

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Mar'26
Jun'26
Total Current Assets
38,672
38,612
35,752
Cash, Cash Equivalents & STI
32,105
30,290
27,943
Accounts Receivable, Net
3,763
5,039
4,427
Inventories
2,301
2,687
2,703
Total Current Liabilities
1,154
1,356
1,288
Payables & Accruals
- -
- -
- -
ST Debt
113
123
142
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
8.19%
Free Cash Flow
- -
- -
-382.45%
Net Income, GAAP
- -
- -
18.41%
Sales/Revenue/Turnover
- -
- -
7.52%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
966
1,684
1,427
3,029
7,105
2025
2,089
2,648
784
- -
7,639
2026
932
1,729
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4.76
47.66
29.02
126.65
409.87
2025
18.1
44.5
-12.06
- -
211.52
2026
-4.34
16.2
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
24.89
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Kwanghoon Park
Full Time Employees
51
Sector
Health technology
Industry
Medical specialties
Address
#509, Woori Venture Town II Seoul SL South Korea
IPO Date
Jul 31, 2024
Website
walkbot.co.kr
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
P&S Robotics Co., Ltd. (460940.KQ) develops, manufactures, and sells robotic rehabilitation systems and automation equipment focused on gait training and mobility restoration for patients with neurological and musculoskeletal impairments. Founded in 2003 and headquartered in Seoul, South Korea, the company provides robotic system solutions internationally, with core products including the Walkbot series of exoskeleton-based gait rehabilitation robots: Walkbot_S for adults featuring three-joint (hip, knee, ankle) training modules, automatic leg-length adjustment, and interactive training modes; Walkbot_G and Walkbot_K for pediatric patients (heights 86-148 cm) with child-specific gait algorithms, playground-themed interfaces, and 1 mm-increment adjustments; Walkbot_P as a modular adult-pediatric interchangeable system with dynamic counterweight assistance; and premium export-oriented models incorporating augmented reality, 3D software, force plate gait analysis, and biofeedback for optimized therapeutic outcomes in conditions such as stroke, spinal cord injury, multiple sclerosis, cerebral palsy, brain tumors, and polio. It also offers maintenance services, humanoid robots, mechanical engineering experimental equipment, and is developing upper-limb systems like Healerbot and infant walking aids like Babybot. In June 2025, the company changed its name from P&S Mechanics Co., Ltd. to P&S Robotics Co., Ltd., reflecting its strategic shift toward broader robotics applications; it listed on South Korea's KOSDAQ exchange in July 2024, enhancing access to capital for expansion, and participated in global events including Arab Health 2025 in Dubai while signing a support agreement with GIST Convergence Technology Institute in February 2025 to advance R&D initiatives.